Respiratory Health of Elite Athletes

NCT ID: NCT00686491

Last Updated: 2011-02-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

133 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-06-30

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area.

Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be

1. to establish a long-term program of systematic evaluation and follow-up of cardiorespiratory health and performance of high elite athletes.
2. to evaluate the prevalence of respiratory, circulatory and metabolic problems among high-level athletes
3. to evaluate the effects of treatments on cardiorespiratory conditions and exercise performance in athletes who need asthma medication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Cardiovascular Diseases Metabolic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Triathletes

No interventions assigned to this group

2

Cold air athletes

No interventions assigned to this group

3

Swimmers

No interventions assigned to this group

4

Other sports elite athletes

No interventions assigned to this group

5

Control subjects

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Athletes training more than 10 hours per week-

Exclusion Criteria

* asthma or other pathologies that may interfere with the study
* Smokers
* Obese of with a BMI more than 29
Minimum Eligible Age

14 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laval University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Institut universitaire de cardiologie et de pneumologie de Québec

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul POIRIER, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpital LAval

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec

Québec, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Bougault V, Blouin E, Turmel J, Boulet LP. Airway response to methacholine following eucapnic voluntary hyperpnea in athletes. PLoS One. 2015 Mar 19;10(3):e0121781. doi: 10.1371/journal.pone.0121781. eCollection 2015.

Reference Type DERIVED
PMID: 25789614 (View on PubMed)

Turmel J, Bougault V, Boulet LP, Poirier P. Exaggerated blood pressure response to exercise in athletes: dysmetabolism or altered autonomic nervous system modulation? Blood Press Monit. 2012 Oct;17(5):184-92. doi: 10.1097/MBP.0b013e3283573509.

Reference Type DERIVED
PMID: 22828668 (View on PubMed)

Bougault V, Turmel J, Boulet LP. Bronchial challenges and respiratory symptoms in elite swimmers and winter sport athletes: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010 Aug;138(2 Suppl):31S-37S. doi: 10.1378/chest.09-1689. Epub 2010 Apr 2.

Reference Type DERIVED
PMID: 20363843 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CER 20141

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.